Stonepine Capital Management’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,176,344
| Closed | -$2.38M | – | 23 |
|
|
2022
Q2 | $2.38M | Sell |
1,176,344
-20,901
| -2% | -$42.2K | 1.11% | 17 |
|
|
2022
Q1 | $2.99M | Buy |
1,197,245
+2,575
| +0.2% | +$6.44K | 1.24% | 17 |
|
|
2021
Q4 | $4.46M | Buy |
1,194,670
+1,028,895
| +621% | +$3.84M | 2.04% | 12 |
|
|
2021
Q3 | $665K | Sell |
165,775
-254,167
| -61% | -$1.02M | 0.3% | 25 |
|
|
2021
Q2 | $1.87M | Sell |
419,942
-603,467
| -59% | -$2.69M | 0.98% | 21 |
|
|
2021
Q1 | $9.36M | Buy |
1,023,409
+73,409
| +8% | +$672K | 5.06% | 8 |
|
|
2020
Q4 | $9.63M | Sell |
950,000
-196,470
| -17% | -$1.99M | 7.37% | 3 |
|
|
2020
Q3 | $4.86M | Buy |
1,146,470
+478,040
| +72% | +$2.03M | 5.06% | 6 |
|
|
2020
Q2 | $4.63M | Sell |
668,430
-156,867
| -19% | -$1.09M | 8.97% | 4 |
|
|
2020
Q1 | $2.31M | Buy |
+825,297
| New | +$2.31M | 2.44% | 20 |
|
|
2019
Q4 | – | Sell |
-13,705
| Closed | -$28K | – | 24 |
|
|
2019
Q3 | $28K | Buy |
+13,705
| New | +$28K | 0.03% | 26 |
|
|
2019
Q2 | – | Sell |
-250,000
| Closed | -$1.14M | – | 27 |
|
|
2019
Q1 | $1.14M | Buy |
+250,000
| New | +$1.14M | 0.65% | 27 |
|